Erdem Goker

Algorithms for scheduling of chemotherapy plans

Suleyman Sevinc, Ulus Ali Sanli, Erdem Goker, 2013, Comput. Biol. Medicine.

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Jianying Zhou, Erdem Goker, Jun Zhao, 2019, The Lancet.